SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000882104-20-000013
Filing Date
2020-01-15
Accepted
2020-01-15 16:34:17
Documents
20
Effectiveness Date
2020-01-15

Document Format Files

Seq Description Document Type Size
1 DEFA-14A12 pdli-20200115defa14adoc.htm DEFA14A 58817
2 slide1b16.jpg GRAPHIC 47741
3 slide2b15.jpg GRAPHIC 211836
4 slide3b15.jpg GRAPHIC 181682
5 slide4b15.jpg GRAPHIC 77809
6 slide5b15.jpg GRAPHIC 158084
7 slide6b15.jpg GRAPHIC 152650
8 slide7b15.jpg GRAPHIC 159661
9 slide8b13.jpg GRAPHIC 145174
10 slide9b12.jpg GRAPHIC 165231
11 slidx79.jpg GRAPHIC 130360
12 slidx80.jpg GRAPHIC 148014
13 slidx81.jpg GRAPHIC 131740
14 slidx82.jpg GRAPHIC 107915
15 slidx83.jpg GRAPHIC 164233
16 slidx84.jpg GRAPHIC 25373
17 slidx85.jpg GRAPHIC 186735
18 slidx86.jpg GRAPHIC 186426
19 slidx87.jpg GRAPHIC 132898
20 slidx88.jpg GRAPHIC 124445
  Complete submission text file 0000882104-20-000013.txt   3694791
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-19756 | Film No.: 20528589
SIC: 2836 Biological Products, (No Diagnostic Substances)